Bleakley Monetary Group LLC lowered its place in Elevance Well being, Inc. (NYSE:ELV – Free Report) by 76.1% within the third quarter, HoldingsChannel reviews. The fund owned 5,817 shares of the corporate’s inventory after promoting 18,556 shares in the course of the interval. Bleakley Monetary Group LLC’s holdings in Elevance Well being had been price $3,025,000 as of its most up-to-date submitting with the SEC.
Different hedge funds and different institutional buyers have additionally purchased and offered shares of the corporate. Massachusetts Monetary Companies Co. MA elevated its holdings in Elevance Well being by 34.0% in the course of the 2nd quarter. Massachusetts Monetary Companies Co. MA now owns 2,062,706 shares of the corporate’s inventory price $1,117,698,000 after buying an extra 523,910 shares in the course of the interval. M&G Plc purchased a brand new place in shares of Elevance Well being within the first quarter price $203,389,000. Maj Make investments Holding A S bought a brand new stake in shares of Elevance Well being within the second quarter price $173,753,000. First Eagle Funding Administration LLC boosted its stake in Elevance Well being by 15.5% in the course of the second quarter. First Eagle Funding Administration LLC now owns 2,058,283 shares of the corporate’s inventory valued at $1,115,301,000 after shopping for an extra 275,708 shares in the course of the interval. Lastly, International Belongings Advisory LLC bought a brand new place in Elevance Well being in the course of the first quarter price about $109,435,000. Institutional buyers personal 89.24% of the corporate’s inventory.
Elevance Well being Inventory Efficiency
NYSE:ELV opened at $430.76 on Friday. The corporate has a debt-to-equity ratio of 0.58, a fast ratio of 1.49 and a present ratio of 1.49. Elevance Well being, Inc. has a fifty-two week low of $397.98 and a fifty-two week excessive of $567.26. The agency has a market cap of $100.12 billion, a PE ratio of 16.28, a price-to-earnings-growth ratio of 1.08 and a beta of 0.82. The enterprise has a 50 day transferring common worth of $526.74 and a 200-day transferring common worth of $527.46.
Elevance Well being (NYSE:ELV – Get Free Report) final introduced its quarterly earnings outcomes on Thursday, October seventeenth. The corporate reported $8.37 earnings per share for the quarter, lacking the consensus estimate of $9.66 by ($1.29). Elevance Well being had a internet margin of three.89% and a return on fairness of 20.64%. The agency had income of $44.72 billion for the quarter, in comparison with analysts’ expectations of $43.47 billion. Throughout the identical interval within the earlier 12 months, the corporate earned $8.99 EPS. The corporate’s quarterly income was up 5.3% on a year-over-year foundation. Equities analysis analysts predict that Elevance Well being, Inc. will publish 37.26 earnings per share for the present 12 months.
Elevance Well being Broadcasts Dividend
The agency additionally just lately introduced a quarterly dividend, which can be paid on Friday, December twentieth. Stockholders of document on Thursday, December fifth can be paid a dividend of $1.63 per share. The ex-dividend date of this dividend is Thursday, December fifth. This represents a $6.52 annualized dividend and a dividend yield of 1.51%. Elevance Well being’s dividend payout ratio (DPR) is presently 24.64%.
Wall Avenue Analyst Weigh In
ELV has been the topic of quite a lot of analysis analyst reviews. Morgan Stanley initiated protection on Elevance Well being in a analysis report on Monday, June twenty fourth. They set an “obese” score and a $643.00 worth goal for the corporate. Raymond James set a $485.00 worth goal on shares of Elevance Well being in a analysis be aware on Friday. UBS Group lowered their worth goal on shares of Elevance Well being from $605.00 to $555.00 and set a “purchase” score on the inventory in a analysis report on Friday. Wells Fargo & Firm reiterated a “purchase” score on shares of Elevance Well being in a analysis report on Friday. Lastly, Barclays elevated their goal worth on Elevance Well being from $611.00 to $622.00 and gave the corporate an “obese” score in a analysis be aware on Thursday, October tenth. One analysis analyst has rated the inventory with a promote score, two have given a maintain score, 13 have assigned a purchase score and one has issued a powerful purchase score to the corporate’s inventory. In keeping with knowledge from MarketBeat, the corporate presently has a consensus score of “Reasonable Purchase” and a median goal worth of $572.27.
Learn Our Newest Inventory Report on ELV
Insider Exercise at Elevance Well being
In different Elevance Well being information, EVP Charles Morgan Kendrick, Jr. offered 7,417 shares of the enterprise’s inventory in a transaction on Friday, October 18th. The shares had been offered at a median worth of $432.14, for a complete transaction of $3,205,182.38. Following the transaction, the chief vice chairman now immediately owns 8,423 shares of the corporate’s inventory, valued at roughly $3,639,915.22. The commerce was a 0.00 % lower of their place. The sale was disclosed in a doc filed with the Securities & Change Fee, which will be accessed by means of the SEC web site. In different Elevance Well being information, EVP Charles Morgan Kendrick, Jr. offered 7,417 shares of the corporate’s inventory in a transaction that occurred on Friday, October 18th. The inventory was offered at a median worth of $432.14, for a complete transaction of $3,205,182.38. Following the transaction, the chief vice chairman now owns 8,423 shares within the firm, valued at roughly $3,639,915.22. This represents a 0.00 % lower of their place. The transaction was disclosed in a authorized submitting with the Securities & Change Fee, which is accessible by means of the SEC web site. Additionally, Director Ramiro G. Peru offered 753 shares of the agency’s inventory in a transaction that occurred on Monday, August fifth. The shares had been offered at a median worth of $531.52, for a complete worth of $400,234.56. Following the completion of the transaction, the director now owns 8,744 shares of the corporate’s inventory, valued at roughly $4,647,610.88. The commerce was a 0.00 % lower of their place. The disclosure for this sale will be discovered right here. Insiders offered a complete of 42,170 shares of firm inventory price $20,638,737 during the last quarter. 0.35% of the inventory is owned by company insiders.
About Elevance Well being
Elevance Well being, Inc, along with its subsidiaries, operates as a well being advantages firm in the US. The corporate operates by means of 4 segments: Well being Advantages, CarelonRx, Carelon Companies, and Company & Different. It gives quite a lot of well being plans and providers to program members; well being merchandise; an array of fee-based administrative managed care providers; and specialty and different insurance coverage services, corresponding to cease loss, dental, imaginative and prescient, life, incapacity, and supplemental medical health insurance advantages.
Featured Tales
Wish to see what different hedge funds are holding ELV? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Elevance Well being, Inc. (NYSE:ELV – Free Report).
Obtain Information & Scores for Elevance Well being Day by day – Enter your e-mail tackle under to obtain a concise day by day abstract of the most recent information and analysts’ scores for Elevance Well being and associated corporations with MarketBeat.com’s FREE day by day e-mail publication.
